Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Vascular Diseases

17 alpha-hydroxyprogesterone caproate has been researched along with Vascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, F; Chekir, C; Emi, Y; Hiramatsu, Y; Kamada, Y; Kikuchi, Y; Matsuda, M; Nakatsuka, M; Sasaki, A; Shimizu, K; Tabuchi, K1

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Vascular Diseases

ArticleYear
Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment.
    The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:6

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Oral; Adult; Cross-Sectional Studies; Drug Implants; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Japan; Male; Medroxyprogesterone; Middle Aged; Progestins; Transsexualism; Vascular Diseases; Vascular Stiffness

2012